| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |